JTL
UTHR icon

Jupiter Topco LLC’s United Therapeutics UTHR Stock Holding History

Jupiter Topco LLC’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$450M Buy
+831,129
New +$468M 0.18% 121

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Jupiter Topco LLC's UTHR Position: Q2 2026 in Review

Jupiter Topco LLC opened a new position in United Therapeutics (UTHR) in Q2 2026: 831,129 shares worth $450M. The stake represents 0.18% of the portfolio and ranks #121 among its holdings.

818 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Jupiter Topco LLC held 831,129 shares of United Therapeutics worth $450M as of Q2 2026.
  • United Therapeutics was a new Jupiter Topco LLC position in Q2 2026.
  • United Therapeutics made up 0.18% of Jupiter Topco LLC's portfolio in Q2 2026, its #121 holding.
  • 818 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Jupiter Topco LLC's 13F filing for Q2 2026, filed 14 Aug 2026.